Improving the management of chemotherapy-induced neutropenia

J Support Oncol. 2004 Mar-Apr;2(2 Suppl 2):36-9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / blood
  • Cytokines / administration & dosage
  • Cytokines / therapeutic use
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Medical Oncology / trends
  • Neoplasms / drug therapy
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy*
  • Polyethylene Glycols
  • Recombinant Proteins

Substances

  • Antineoplastic Agents
  • Cytokines
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Filgrastim